PFIZER INC·4

Mar 6, 1:58 PM ET

Denton David M 4

4 · PFIZER INC · Filed Mar 6, 2025

Insider Transaction Report

Form 4
Period: 2025-03-04
Denton David M
Chief Financial Officer & EVP
Transactions
  • Award

    Stock Appreciation Rights

    2025-03-04+413,138413,138 total
    Exercise: $25.75From: 2030-03-04Exp: 2030-03-04Common Stock (413,138 underlying)
Footnotes (1)
  • [F1]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

Documents

2 files